PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Resource Needs for the Trivalent Oral Polio to Bivalent Oral Polio Vaccine Switch in Indonesia.

Abstract We present an empirical economic cost analysis of the April 2016 switch from trivalent (tOPV) to bivalent (bOPV) oral polio vaccine at the national-level and 3 provinces (Bali, West Sumatera and Nusa Tenggara) for Indonesia's Expanded Program on Immunization.
PMID
Related Publications

Polio inactivated vaccine costs into routine childhood immunization in Brazil.

Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine - Worldwide, 2016.

Introduction of Inactivated Poliovirus Vaccine and Switch from Trivalent to Bivalent Oral Poliovirus Vaccine - Worldwide, 2013-2016.

Monitoring and Validation of the Global Replacement of tOPV with bOPV, April-May 2016.

Implementing the Synchronized Global Switch from Trivalent to Bivalent Oral Polio Vaccines-Lessons Learned From the Global Perspective.

Authors

Mayor MeshTerms

Immunization Programs

Poliovirus Vaccine, Oral

Keywords

Indonesia

cost analysis

resource utilization

vaccine switch

Journal Title the journal of infectious diseases
Publication Year Start




PMID- 28838204
OWN - NLM
STAT- MEDLINE
DA  - 20170825
DCOM- 20170905
LR  - 20170906
IS  - 1537-6613 (Electronic)
IS  - 0022-1899 (Linking)
VI  - 216
IP  - suppl_1
DP  - 2017 Jul 01
TI  - Resource Needs for the Trivalent Oral Polio to Bivalent Oral Polio Vaccine Switch
      in Indonesia.
PG  - S209-S216
LID - 10.1093/infdis/jix073 [doi]
AB  - Background: We present an empirical economic cost analysis of the April 2016
      switch from trivalent (tOPV) to bivalent (bOPV) oral polio vaccine at the
      national-level and 3 provinces (Bali, West Sumatera and Nusa Tenggara) for
      Indonesia's Expanded Program on Immunization. Methods: Data on the quantity and
      prices of resources used in the 4 World Health Organization guideline phases of
      the switch were collected at the national-level and in each of the sampled
      provinces, cities/districts, and health facilities. Costs were calculated as the 
      sum of the value of resources reportedly used in each sampled unit by switch
      phase. Results: Estimated national-level costs were $46 791. Costs by health
      system level varied from $9062 to $34 256 at the province-level, from $4576 to
      $11 936 at the district-level , and from $3488 to $29 175 at the city-level.
      Estimated national costs ranged from $4 076 446 (Bali, minimum cost scenario) to 
      $28 120 700 (West Sumatera, maximum cost scenario). Conclusions: Our findings
      suggest that the majority of tPOV to bOPV switch costs were borne at the
      subnational level. Considerable variation in reported costs among health system
      levels surveyed indicates a need for flexibility in budgeting for globally
      synchronized public health activities.
FAU - Holmes, Marionette
AU  - Holmes M
AD  - Global Immunization Division, US Centers for Disease Control and Prevention.
AD  - Economics Department, Spelman College, Atlanta, Georgia.
FAU - Abimbola, Taiwo
AU  - Abimbola T
AD  - Global Immunization Division, US Centers for Disease Control and Prevention.
FAU - Lusiana, Merry
AU  - Lusiana M
AD  - Policy Unit, Ministry of Health, Jakarta, Indonesia.
FAU - Pallas, Sarah
AU  - Pallas S
AD  - Global Immunization Division, US Centers for Disease Control and Prevention.
FAU - Hampton, Lee M
AU  - Hampton LM
AD  - Global Immunization Division, US Centers for Disease Control and Prevention.
FAU - Widyastuti, Retno
AU  - Widyastuti R
AD  - Policy Unit, Ministry of Health, Jakarta, Indonesia.
FAU - Muas, Idawati
AU  - Muas I
AD  - Policy Unit, Ministry of Health, Jakarta, Indonesia.
FAU - Karlina, Karlina
AU  - Karlina K
AD  - Policy Unit, Ministry of Health, Jakarta, Indonesia.
FAU - Kosen, Soewarta
AU  - Kosen S
AD  - Policy Unit, Ministry of Health, Jakarta, Indonesia.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - J Infect Dis
JT  - The Journal of infectious diseases
JID - 0413675
RN  - 0 (Poliovirus Vaccine, Oral)
SB  - AIM
SB  - IM
MH  - Costs and Cost Analysis
MH  - Drug Substitution
MH  - Humans
MH  - *Immunization Programs/economics/statistics & numerical data/supply &
      distribution
MH  - Indonesia/epidemiology
MH  - Poliomyelitis/*prevention & control
MH  - *Poliovirus Vaccine, Oral/administration & dosage/economics/supply & distribution
OTO - NOTNLM
OT  - Indonesia
OT  - cost analysis
OT  - resource utilization
OT  - vaccine switch
EDAT- 2017/08/26 06:00
MHDA- 2017/09/07 06:00
CRDT- 2017/08/26 06:00
AID - 3935087 [pii]
AID - 10.1093/infdis/jix073 [doi]
PST - ppublish
SO  - J Infect Dis. 2017 Jul 1;216(suppl_1):S209-S216. doi: 10.1093/infdis/jix073.